Multipotent stem cell and current application

Acta Medica Iranica

Volumn 55, Issue 1, 2017, Pages 6-23

  Sobhani, Aligholi ^a   Khanlarkhani, Neda ^a   Baazm, Maryam ^b   Mohammadzadeh, Farzaneh ^a   Najafi, Atefeh ^a   Mehdinejadiani, Shayesteh ^a   Aval, Fereydoon Sargolzaei ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Fertility; Multipotent; Preservation; Regenerative medicine; Stem cell

Indexed keywords

CELL SURFACE MARKER;

AUTOIMMUNE DISEASE; CARDIOVASCULAR DISEASE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; FERTILITY PRESERVATION; FRACTURE; HUMAN; INFERTILITY; INFLAMMATORY BOWEL DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; LIVER DISEASE; LUNG DISEASE; MULTIPOTENT STEM CELL; NERVE REGENERATION; NONHUMAN; OSTEOARTHROPATHY; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SPINAL CORD INJURY; TISSUE REPAIR; ADULT; ANIMAL; CYTOLOGY; PHYSIOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ADULT; ANIMALS; CELL DIFFERENTIATION; HUMANS; MULTIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

EID: 85012023552     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Review

References (167)

1. Bongso A, Fong CY. Human embryonic stem cells: their nature, properties, and uses, in Trends in Stem Cell Biology and Technology. Springer 2009:1-17.
2. Hosseinkhani H, Hosseinkhani M. Tissue engineered Scaffolds for stem cells and regenerative medicine, in Trends in Stem Cell Biology and Technology. Springer 2009;367-87.
3. Gargett CE. Adult stem cells in the human endometrium. In: Simon C, Pellicer A, eds. Stem Cells in Human Reproduction: Basic Science and Therapeutic Potential. 2nd ed. London: Informa Healthcare, 2009:160-76.
4. Alison MR, Poulsom R, Forbes S, Wright NA. An introduction to stem cells. J Pathol 2002;197:419-23.
5. Larijani B, Esfahani EN, Amini P, Nikbin B, Alimoghaddam K, Amiri S, et al. Stem cell therapy in treatment of different diseases. Acta Med Iran 2012;50:79-96.
6. Smith A. The battlefield of pluripotency. Cell 2005;123:757-60.
7. Fu RH, Wang YC, Liu SP, Huang CM, Kang YH, Tsai CH, et al. Differentiation of stem cells: strategies for modifying surface biomaterials. Cell Transplant 2010;20:37-47.
8. Board S. Stem cells--scientific, medical, and political issues. N Engl J Med 2002;346:1576-9.
9. Li L, Xie T. Stem cell niche: structure and function. Ann Rev Cell Dev Biol 2005;21:605-31.
10. Nandedkar T, Narkar M. Stem cell research: its relevance to reproductive biology. IJEB 2003;41:724-39.
11. Bunnell BA, Flaat M, Gagliardi C, Patel B, Ripoll C. Adipose-derived stem cells: isolation, expansion and differentiation. Methods 2008;45:115-20.
12. Yoshida Y, Yamanaka S. iPS cells: a source of cardiac regeneration. J Mol Cell Cardiol 2011;50:327-32.
13. Niibe K, Kawamura Y, Araki D, Morikawa S, Miura K, Suzuki S, et al. Purified mesenchymal stem cells are an efficient source for iPS cell induction. PLoS One 2011;6:e17610.
14. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 2008;132:567-82.
15. Krampera M, Franchini M, Pizzolo G, Aprili G. Mesenchymal stem cells: from biology to clinical use. Blood Transfus 2007;5:120-9.
16. Woods DC, White YA, Tilly JL. Purification of oogonial stem cells from adult mouse and human ovaries: an assessment of the literature and a view toward the future. Reprod Sci 2013;20:7-15.
17. Wakao S, Kitada M, Kuroda Y, Shigemoto T, Matsuse D, Akashi H, et al. Multilineage-differentiating stress-enduring (Muse) cells are a primary source of induced pluripotent stem cells in human fibroblasts. Proc Natl Acad Sci U. S. A. 2011;108:9875-80.
18. Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013;45:e54.
19. Mundra V, Gerling IC, Mahato RI. Mesenchymal stem cell-based therapy. Mol Pharm 2012;10:77-89.
20. Bibber B, Sinha G, Lobba AR, Greco SJ, Rameshwar P. A Review of Stem Cell Translation and Potential Confounds by Cancer Stem Cells. Stem Cells Int 2013;2013:241048.
21. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001;98:2396-402.
22. Chen FM, Wu LA, Zhang M, Zhang R, Sun HH. Homing of endogenous stem/progenitor cells for in situ tissue regeneration: Promises, strategies, and translational perspectives. Biomaterials 2011;32:3189-209.
23. He Q, Wan C, Li G. Concise review: multipotent mesenchymal stromal cells in blood. Stem Cell 2007;25:69-77.
24. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues: cloning in vitro and retransplantation in vivo. Transplant 1974;17:331-40.
25. Weiss DJ, Bertoncello I, Borok Z, Kim C, Panoskaltsis-Mortari A, Reynolds S, et al. Stem cells and cell therapies in lung biology and lung diseases. Proc Am Thoracic Soc 2011;8:223-72.
26. Yagi H, Soto-Gutierrez A, Kitagawa Y, Tilles AW, Tompkins AG, Yarmush ML. Bone marrow mesenchymal stromal cells attenuate organ injury induced by LPS and burn. Cell Transplant 2010;19:823-30.
27. Guan XJ, Song L, Han FF, Cui ZL, Chen X, Guo XJ, et al. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF– VEGF receptors. J Cell Biochem 2013;114:323-35.
28. Khanlarkhani N, Atlasi MA, Kashani R, Naderian H, Taherian AA, Nikzad H. The effects of progestrone on the in-vitro expression of P0, S100 and Krox20 genes in adipose-derived stem cells. Tehran Univ Med J 2011;69:67-74.
29. Caplan AI, Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011;9:11-5.
30. Caplan AI. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 2007;213:341-7.
31. Haynesworth S, Barer M, Caplan A. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80.
32. Butti E, Cusimano M, Bacigaluppi M, Martino G. Neurogenic and non-neurogenic functions of endogenous neural stem cells. Frontiers Neurosci 2014;8:92.
33. Kennea NL, Mehmet H. Neural stem cells. J Pathol 2002;197:536-50.
34. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park TS, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3:301-13.
35. Traktuev DO, Merfeld-Clauss S, Li J, Kolonin M, Arap W, Pasqualini R, et al. A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks. Circ Res 2008;102:77-85.
36. Zimmerlin L, Donnenberg VS, Rubin JP, Donnenberg AD. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry Part A 2013;83:134-40.
37. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-7.
38. Tsao CW, Chiang MZ, Cheng YC. Effects of Chemical and Physical Shear-Stress Stimulation of Human Placenta-Derived Multipotent Stem Cells in Microchannel. Proceedings of the ASME 2013 11th International Conference on Nanochannels, Microchannels, and Minichannels, 2013.
39. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002;13:4279-95.
40. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow‐derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL‐1α. J Cell Physiol 1996;166:585-92.
41. Haynesworth SE, Baber MA, Caplan AI. Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cells. Biomaterials 2011;32:6089-98.
42. Caplan AI, Bruder SP. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol Med 2001;7:259-64.
43. Chen L, Tredget EE, Wu PY, Wu Y. Paracrine factors of mesenchymal stem cells recruit macrophages and endothelial lineage cells and enhance wound healing. PloS One 2008;3:e1886.
44. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005;105:1815-22.
45. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 2006;20:661-9.
46. Yoshimura H, Muneta T, Nimura A, Yokoyama A, Koga H, Sekiya I. Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res 2007;327:449-62.
47. Bianco P, Riminucci M, Gronthos S, Robey PG. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cell 2001;19:180-92.
48. Kucia M, Wysoczynski M, Ratajczak J, Ratajczak M. Identification of very small embryonic like (VSEL) stem cells in bone marrow. Cell Tissue Res 2008;331:125-34.
49. Kucia, M., R. Reca, F. Campbell, E. Zuba-Surma, M. Majka, J. Ratajczak, et al., A population of very small embryonic-like (VSEL) CXCR4+ SSEA-1+ Oct-4+ stem cells identified in adult bone marrow. Leukemia, 2006. 20(5): p. 857-869.
50. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol 2004;36:568-84.
51. Chamberlain G, Fox J, Ashton B, Middleton J. Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cell 2007;25:2739-49.
52. Waller EK, Olweus J, Lund-Johansen F, Huang S, Nguyen M, Guo G, et al. The common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate populations of hematopoietic and stromal progenitors. Blood 1995;85:2422-35.
53. Yamamoto N, Akamatsu H, Hasegawa S, Yamada T, Nakata S, Ohkuma M, et al. Isolation of multipotent stem cells from mouse adipose tissue. J Dermatol Sci 2007;48:43-52.
54. Gronthos S, Franklin DM, Leddy HA, Robey PG, Storms RW, Gimble JM. Surface protein characterization of human adipose tissue‐derived stromal cells. J Cell Physiol 2001;189:54-63.
55. Schäffler A, Büchler C. Concise Review: Adipose Tissue‐ Derived Stromal Cells—Basic and Clinical Implications for Novel Cell‐Based Therapies. Stem Cell 2007;25:818-27.
56. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S. Postnatal human dental pulp stem cells (DPSCs) in vitro and in vivo. Proc Natl Acad Sci U.S.A. 2000;97:13625-30.
57. Jo YY, Lee HJ, Kook SY, Choung SW, Park JY, Chung JH, et al. Isolation and characterization of postnatal stem cells from human dental tissues. Tissue Eng 2007;13:767-73.
58. Pierdomenico L, Bonsi L, Calvitti M, Rondelli D, Arpinati M, Chirumbolo G, et al. Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp. Transplant 2005;80:836-42.
59. Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, et al. Characterization and isolation of stem cell–enriched human hair follicle bulge cells. J Clin Invest 2006;116:249-60.
60. Varma MJO, Breuls RG, Schouten TE, Jurgens WJ, Bontkes HJ, Schuurhuis GJ, et al. Phenotypical and functional characterization of freshly isolated adipose tissue-derived stem cells. Stem Cell Dev 2007;16:91-104.
61. Tuan RS. Stemming cartilage degeneration: adult mesenchymal stem cells as a cell source for articular cartilage tissue engineering. Arthrit Rheum 2006;54:3075-8.
62. Murphy SV, Atala A. Amniotic fluid and placental membranes: unexpected sources of highly multipotent cells. Semin Reprod Med 2013;31:62-8.
63. Miyahara Y, Nagaya N, Kataoka M, Yanagawa B, Tanaka K, Hao H, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 2006;12:459-65.
64. Dai W, Hale SL, Martin BJ, Kuang JQ, Dow KS, Wold LE, et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium short-and long-term effects. Circulation 2005;112:214-23.
65. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, et al. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res 2010;107:913-22.
66. Kuraitis D, Ruel M, Suuronen EJ. Mesenchymal stem cells for cardiovascular regeneration. Cardiovasc Drugs Ther 2011;25:349-62.
67. Bollini S, Cheung KK, Riegler J, Dong X, Smart N, Ghionzoli M, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cell Dev 2011;20:1985-94.
68. Lee WY, Wei HJ, Lin WW, Yeh YC, Hwang SM, Wang JJ, et al. Enhancement of cell retention and functional benefits in myocardial infarction using human amniotic-fluid stem-cell bodies enriched with endogenous ECM. Biomaterials 2011;32:5558-67.
69. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009;54:2277-86.
70. Chen S, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. J Am Coll Cardiol 2004;94:92-5.
71. Williams AR, Trachtenberg B, Velazquez DL, McNiece L, Altman P, Rouy D, et al. Intramyocardial Stem Cell Injection in Patients With Ischemic Cardiomyopathy Functional Recovery and Reverse Remodeling. Circ Res 2011;108:792-6.
72. Traverse JH, Henry TD, Pepine CJ, Willerson JT, Zhao DX, Ellis SG, et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 2012;308:2380-9.
73. Haack-Sorensen M, Friis T, Mathiasen AB, Jorgensen E, Hansen L, Dickmeiss E, et al. Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up. Cell Transplant 2013;22:521-8.
74. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cell Dev 2009;18:683-92.
75. Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, et al. Cardiopoietic Stem Cell Therapy in Heart FailureThe C-CURE (Cardiopoietic stem Cell therapy in heart failURE) Multicenter Randomized Trial With Lineage-Specified Biologics. J Am Coll Cardiol 2013;61:2329-38.
76. Zheng GP, Ge MH, Shu Q, Rojas M, Xu J. Mesenchymal stem cells in the treatment of pediatric diseases. World J Pediatr 2013;9:197-211.
77. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YRV, Fang SCY, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134:2111-21.
78. van Poll D, Parekkadan B, Cho CH, Berthiaume F, Nahmias Y, Tilles AW, et al. Mesenchymal stem cell– derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 2008;47:1634-43.
79. Khuu DN, Nyabi O, Maerckx C, Sokal E, Najimi M. Adult human liver mesenchymal stem/progenitor cells participate in mouse liver regeneration after hepatectomy. Cell Transplant 2013;22:1369-80.
80. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007;10:459-66.
81. Kharaziha P, Hellström PM, Noorinayer B, Farzaneh F, Aghajani K, Jafari F, et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I–II clinical trial. Eur J Gastroenterol Hepatol 2009;21:1199-205.
82. Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, et al. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol 2012;27:112-20.
83. Peng L, Xie DY, Lin BL, Liu J, Zhu HP, Xie C, et al. Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes. Hepatology 2011;54:820-8.
84. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum 2005;48:1416-23.
85. Garcia-Olmo D, Herreros D, Pascual I, Pascual JA, Del-Valle E, Zorrilla J, et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis. Colon Rectum 2009;52:79-86.
86. Duijvestein M, Vos ACW, Roelofs H, Wildenberg ME, Wendrich BB, Verspaget HW, et al. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 2010;59:1662-9.
87. Ciccocioppo R, Bernardo ME, Sgarella A, Maccario R, Avanzini MA, Ubezio C, et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 2011;60:788-98.
88. Goel A, Sangwan S, Siwach R, Ali AM. Percutaneous bone marrow grafting for the treatment of tibial nonunion. Injury 2005;36:203-6.
89. Hernigou P, Poignard A, Manicom O, Mathieu G, Rouard H. The use of percutaneous autologous bone marrow transplantation in nonunion and avascular necrosis of bone. J Bone Joint Surg Br 2005;87:896-902.
90. De Coppi P, Bartsch G, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25:100-6.
91. Kashani IR, Zaminy A, Barbarestani M, Hedayatpour A, Mahmoudi R, Vardasbi S, et al. In vitro osteogenesis of rat adipose-derived stem cells: comparison with bone marrow stem cells. Arch Med Sci 2009;5:149-55.
92. Kumar S, Ponnazhagan S. Mobilization of bone marrow mesenchymal stem cells in vivo augments bone healing in a mouse model of segmental bone defect. Bone 2012;50:1012-8.
93. Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther 2008;10:223.
94. Tuan RS, Chen AF, Klatt BA. Cartilage regeneration. J Am Acad Orthop Surg 2013;21:303-11.
95. Lee KB, Hui JH, Song IC, Ardany L, Lee EH. Injectable mesenchymal stem cell therapy for large cartilage defects—a porcine model. Stem Cell 2007;25:2964-71.
96. Liu Y, Shu XZ, Prestwich GD. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng 2006;12:3405-16.
97. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Osteoarthr Cartil 2002;10:199-206.
98. Guilak F, Estes BT, Diekman BO, Moutos FT, Gimble JM. 2010 Nicolas Andry Award: Multipotent adult stem cells from adipose tissue for musculoskeletal tissue engineering. Clin Orthop Relat Res 2010;468:2530-40.
99. Viña JA, El-Alami M, Gambini J, Borras C, Viña J, Peñarrocha MA. Application of mesenchymal stem cells in bone regenerative procedures in oral implantology. A literature review. J Clin Exp Dent 2014;6:e60-5.
100. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, et al. Human and murine amniotic fluid c-Kit+ Lin− cells display hematopoietic activity. Blood 2009;113:3953-60.
101. Carrion F, Nova E, Ruiz C, Diaz F, Inostroza C, Rojo D, et al. Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients. Lupus 2010;19:317-22.
102. Liang J, Zhang H, Hua B, Wang H, Lu L, Shi S, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 2010;69:1423-9.
103. Wang D, Akiyama K, Zhang H, Yamaza T, Li X, Feng X, et al. Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus. Clin Dev Immunol 2012;2012:273291.
104. Jones EA, English A, Henshaw K, Kinsey SE, Markham SF, Emery P, et al. Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arthritis Rheum 2004;50:817-27.
105. Endres M, Neumann K, Häupl T, Erggelet C, Ringe J, Sittinger M, et al. Synovial fluid recruits human mesenchymal progenitors from subchondral spongious bone marrow. J Orthop Res 2007;25:1299-307.
106. Jones E, Churchman S, English A, Buch M, Horner E, Burgoyne C, et al. Mesenchymal stem cells in rheumatoid synovium: enumeration and functional assessment in relation to synovial inflammation level. Ann Rheum Dis 2010;69:450-7.
107. Kastrinaki MC, Sidiropoulos P, Roche S, Ringe J, Lehmann S, Kritikos H, et al. Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis. Ann Rheum Dis 2008;67:741-9.
108. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by β cell regeneration. J Clin Invest 2007;117:2553-61.
109. Wei, J.P., T.S. Zhang, S. Kawa, T. Aizawa, M. Ota, T. Akaike, et al., Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell transplant, 2003. 12(5): p. 545-552.
110. Chang CM, Kao CL, Chang YL, Yang MJ, Chen YC, Sung BL, et al. Placenta-derived multipotent stem cells induced to differentiate into insulin-positive cells. Biochem Biophys Res Commun 2007;357:414-20.
111. Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 2009;183:993-1004.
112. Hisanaga E, Park KY, Yamada S, Hashimoto H, Takeuchi T, Mori M, et al. A simple method to induce differentiation of murine bone marrow mesenchymal cells to insulin-producing cells using conophylline and betacellulin-delta4. Endocr J 2008;55:535-43.
113. Oh SH, Muzzonigro TM, Bae SH, LaPlante JM, Hatch HM, Petersen BE. Adult bone marrow-derived cells trans-differentiating into insulin-producing cells for the treatment of type I diabetes. Lab. Invest., 2004. 84(5): p. 607-617.
114. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U.S.A. 2006;103:17438-43.
115. Murphy S, Lim R, Dickinson H, Acharya R, Rosli S, Jenkin G, et al. Human amnion epithelial cells prevent bleomycin-induced lung injury and preserve lung function. Cell Transplant 2011;20:909-23.
116. Murphy SV, Shiyun S, Tan JL, Chan S, Jenkin G, Wallace EJ, et al. Human amnion epithelial cells do not abrogate pulmonary fibrosis in mice with impaired macrophage function. Cell Transplant;2012:21:1477-92.
117. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci U.S.A. 2003;100:8407-11.
118. Rojas M, Xu J, Woods CR, Mora AL, Spears W, Roman J, et al. Bone marrow–derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-52.
119. Mei SH, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med 2007;4:e269.
120. Krasnodembskaya A, Song Y, Fang X, Gupta N, Serikov V, Lee JW, et al. Antibacterial Effect of Human Mesenchymal Stem Cells Is Mediated in Part from Secretion of the Antimicrobial Peptide LL‐37. Stem Cell 2010;28:2229-38.
121. Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson NA, et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U.S.A. 2005;102:186-91.
122. Sueblinvong V, Loi R, Eisenhauer PL, Bernstein IM, Suratt B, Spees JL, et al. Derivation of lung epithelium from human cord blood–derived mesenchymal stem cells. Am J Respir Crit Care Med 2008;177:701.
123. Perin L, Giuliani S, Jin D, Sedrakyan S, Carraro G, Habibian R, et al. Renal differentiation of amniotic fluid stem cells. Cell Prolif 2007;40:936-48.
124. Perin L, Sedrakyan S, Giuliani S, Da Sacco S, Carraro G, Shiri L, et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PloS One 2010;5:e9357.
125. Rehni AK, Singh N, Jaggi AS, Singh M. Amniotic fluid derived stem cells ameliorate focal cerebral ischaemia-reperfusion injury induced behavioural deficits in mice. Behav. Brain Res 2007;183:95-100.
126. Kashani IR, Golipoor Z, Akbari M, Mahmoudi R, Azari S, Shirazi R, et al. Schwann-like cell differentiation from rat bone marrow stem cells. Arch Med Sci 20117:45-52.
127. Aponte PM, Schlatt S, Franca LR. Biotechnological approaches to the treatment of aspermatogenic men. Clinics 2013;68:157-67.
128. Itman C, Mendis S, Barakat B. All in the family: TGF-β family action in testis development. Reproduction 2006;132:233-46.
129. Kobayashi H, Nagao K, Nakajima K. Focus issue on male infertility. Adv Urol 2011;2012:6.
130. Rooij DG, Russell LD. All you wanted to know about spermatogonia but were afraid to ask. J Androl 2000;21:776-98.
131. Kobayashi H, Nagao K, Nakajima K. Therapeutic Advances in the Field of Male Infertility. Stem Cell Res 2013;1:39-54.
132. Marques-Mari A, Lacham-Kaplan O, Medrano J, Pellicer A, Simón C. Differentiation of germ cells and gametes from stem cells. Hum Reprod Update 2009;15:379-90.
133. Hua J, Yu H, Dong W, Yang C, Gao Z, Lei A, et al. Characterization of mesenchymal stem cells (MSCs) from human fetal lung: potential differentiation of germ cells. Tissue Cell 2009;41:448-55.
134. Hua J, Pan S, Yang C, Dong W, Dou Z, Sidhu KS. Derivation of male germ cell-like lineage from human fetal bone marrow stem cells. Reprod. Biomed. Online 2009;19:99-105.
135. Drusenheimer N, Wulf G, Nolte J, Lee JH, Dev A, Dressel R, et al. Putative human male germ cells from bone marrow stem cells. Soc Reprod Fertil Suppl 2006;63:69-76.
136. Hosseinzadeh Shirzeily M, Pasbakhsh P, Amidi F, Mehrannia K. Comparison of differentiation potential of male mouse adipose tissue and bone marrow derived-mesenchymal stem cells into germ cells. Iran J Reprod Med 2013;11:965-76.
137. Nayernia K, Lee JH, Drusenheimer N, Nolte J, Wulf G, Dressel R, et al. Derivation of male germ cells from bone marrow stem cells. Lab Invest 2006;86:654-63.
138. Lue Y, Erkkila K, Liu PY, Ma K, Wang C, Hikim AS, et al. Fate of bone marrow stem cells transplanted into the testis: potential implication for men with testicular failure. Am J Pathol 2007;170:899-908.
139. Monsefi M, Fereydouni B, Rohani L, Talaei T. Mesenchymal stem cells repair germinal cells of seminiferous tubules of sterile rats. Iran J Reprod Med 2013;11:537-44.
140. Zhao XH, Qiu JH, Cai WQ, Li S, Li W. Preparation of infertile male rabbits by local electron beam irradiation for intratesticular transplantation of autologous bone marrow stem cells. Acta Cirurgica Brasileira 2013;28:148-53.
141. Boivin J, Bunting L, Collins JA, Nygren KG. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. Hum Reprod 2007;22:1506-12.
142. Gong SP, Lee ST, Lee EJ, Kim DY, Lee G, Chi SG, et al. Embryonic stem cell-like cells established by culture of adult ovarian cells in mice. Fertil Steril 2010;93:2594-601.
143. Zuckerman S, Baker T. The development of the ovary and the process of oogenesis. Ovary 1977;1:41-67.
144. Zuckerman S. The number of oocytes in the mature ovary. Recent Prog Horm Res 1951;6:63-109.
145. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428:145-50.
146. McGuckin C, Forraz N, Baradez MO, Navran S, Zhao J, Urban R, et al. Production of stem cells with embryonic characteristics from human umbilical cord blood. Cell Prolif 2005;38:245-55.
147. Miki T, Lehmann T, Cai H, Stolz DB. Stem cell characteristics of amniotic epithelial cells. Stem Cell 2005;23:1549-59.
148. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7.
149. Barnes D, Loutit J. Haemopoietic stem cells in the peripheral blood. Lancet 1967;290:1138-41.
150. Alonso L, Fuchs E. Stem cells of the skin epithelium. Proc. Natl Acad Sci U.S.A. 2003;100:11830-5.
151. Guan K, Nayernia K, Maier LS, Wagner S, Dressel R, Lee JH, et al. Pluripotency of spermatogonial stem cells from adult mouse testis. Nature 2006;440:1199-203.
152. Toyooka Y, Tsunekawa N, Akasu R, Noce T. Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci 2003;100:11457-62.
153. Hübner K, Fuhrmann G, Christenson LK, Kehler J, Reinbold R, De La Fuente R, et al. Derivation of oocytes from mouse embryonic stem cells. Science 2003;300:1251-6.
154. Clark AT, Bodnar MS, Fox M, Rodriquez RT, Abeyta MJ, Firpo MT, et al. Spontaneous differentiation of germ cells from human embryonic stem cells in vitro. Hum Mol Genet 2004;13:727-39.
155. Geijsen N, Horoschak M, Kim K, Gribnau J, Eggan K, Daley GQ. Derivation of embryonic germ cells and male gametes from embryonic stem cells. Nature 2004;427: 148-54.
156. Bukovsky A, Svetlikova M, Caudle MR. Oogenesis in cultures derived from adult human ovaries. Reprod Biol Endocrinol 2005;3:17.
157. Virant-Klun I, Zech N, Rožman P, Vogler A, Cvjetičanin B, Klemenc P, et al. Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes. Differentiation 2008;76:843-56.
158. Virant-Klun I, Rozman P, Cvjeticanin B, Vrtacnik-Bokal E, Novakovic S, Rülicke T, et al. Parthenogenetic embryo-like structures in the human ovarian surface epithelium cell culture in postmenopausal women with no naturally present follicles and oocytes. Stem Cell Dev 2009;18:137-50.
159. Virant-Klun I, Skutella T, Stimpfel M, Sinkovec J. Ovarian surface epithelium in patients with severe ovarian infertility: a potential source of cells expressing markers of pluripotent/multipotent stem cells. J Biomed Biotechnol 2011;2011:381928.
160. Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, Adams GB, Niikura Y, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 2005;122:303-15.
161. Saitou M, Barton SC, Surani MA, A molecular programme for the specification of germ cell fate in mice. Nature 2002;418:293-300.
162. Suzumori N, Yan C, Matzuk MM, Rajkovic A. Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes. Mech Dev 2002;111:137-41.
163. Peng L, Jia Z, Yin X, Zhang X, Liu Y, Chen P, et al. Comparative analysis of mesenchymal stem cells from bone marrow, cartilage, and adipose tissue. Stem Cell Dev 2008;17:761-74.
164. Dyce PW, Wen L, Li J, In vitro germline potential of stem cells derived from fetal porcine skin. Nat. Cell Biol 2006;8:384-90.
165. Song SH, Kumar BM, Kang EJ, Lee YM, Kim TH, Ock SA, et al. Characterization of porcine multipotent stem/stromal cells derived from skin, adipose, and ovarian tissues and their differentiation in vitro into putative oocyte-like cells. Stem Cell Dev 2011;20:1359-70.
166. Stimpfel M, Skutella T, Cvjeticanin B, Meznaric M, Dovc P, Novakovic S, et al. Isolation, characterization and differentiation of cells expressing pluripotent/multipotent markers from adult human ovaries. Cell Tissue Res 2013;354:593-607.
167. Lee YM, Kumar BM, Lee JH, Lee WJ, Kim TH, Lee SL, et al. Characterisation and differentiation of porcine ovarian theca-derived multipotent stem cells. Vet J 2013;197:761-8.